Recombinant human IgG molecules lacking Fcγ receptor I binding and monocyte triggering activities

作者: Kathryn L. Armour , Mike R. Clark , Andrew G. Hadley , Lorna M. Williamson

DOI: 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J

关键词:

摘要: Subclasses of human IgG have a range activity levels with different effector systems but each triggers at least one mechanism cell destruction. We are aiming to engineer non-destructive constant regions for therapeutic applications where depletion cells bearing the target antigen is undesirable. The attributes required lack killing via Fcgamma receptors (R) and complement retention neonatal FcR binding maintain placental transport prolonged half-life IgG. Eight variants were made anti-RhD CD52 specificities. mutations, in or two key CH2 domain, restricted incorporation motifs from other subclasses minimize potential immunogenicity. IgG2 residues positions 233 - 236, substituted into IgG1 IgG4, reduced FcgammaRI by 10(4)-fold eliminated monocyte response antibody-sensitized red blood cells, resulting antibodies which blocked functions active antibodies. If glycine deleted IgG2, was restored IgG4 mutants, low observed. Introduction 327, 330 331 had no effect on caused small decrease triggering.

参考文章(33)
MJ van Vugt, IA Heijnen, PJ Capel, SY Park, C Ra, T Saito, JS Verbeek, JG van de Winkel, FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo Blood. ,vol. 87, pp. 3593- 3599 ,(1996) , 10.1182/BLOOD.V87.9.3593.BLOODJOURNAL8793593
Lorna M. Williamson, Gerald Hackett, Janet Rennie, Christopher R. Palmer, Caroline Maciver, Ruth Hadfield, Darren Hughes, Shirley Jobson, Willem H. Ouwehand, The Natural History of Fetomaternal Alloimmunization to the Platelet-Specific Antigen HPA-1a (PlA1, Zwa) as Determined by Antenatal Screening Blood. ,vol. 92, pp. 2280- 2287 ,(1998) , 10.1182/BLOOD.V92.7.2280
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
D R Burton, Y Arata, M R Walker, R Jefferis, J Lund, T Tanaka, P T Jones, P J Artymiuk, J D Pound, G Winter, Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG. Journal of Immunology. ,vol. 147, pp. 2657- 2662 ,(1991)
A M Nesbitt, L Chaplin, N D Jones, M W Bodmer, A Morgan, J S Emtage, The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding. Immunology. ,vol. 86, pp. 319- 324 ,(1995)
Michael R. Clark, IgG Effector Mechanisms Chemical Immunology. ,vol. 65, pp. 88- 110 ,(1996) , 10.1159/000319350
G T Spierenburg, H Frasa, J G van de Winkel, B J Bast, J H Boot, P Koolwijk, Interaction between hybrid mouse monoclonal antibodies and the human high-affinity IgG FcR, huFc gamma RI, on U937. Involvement of only one of the mIgG heavy chains in receptor binding. Journal of Immunology. ,vol. 143, pp. 1656- 1662 ,(1989)
Alexander R. Duncan, Jennifer M. Woof, Lynda J. Partridge, Dennis R. Burton, Greg Winter, Localization of the binding site for the human high-affinity Fc receptor on IgG Nature. ,vol. 332, pp. 563- 564 ,(1988) , 10.1038/332563A0
Andrew G. Hadley, Anthony Wilkes, Jean Goodrick, David Penman, Peter Soothill, Geoffrey Lucas, The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn British Journal of Obstetrics and Gynaecology. ,vol. 105, pp. 231- 234 ,(1998) , 10.1111/J.1471-0528.1998.TB10059.X